Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

1 day ago 5

Intellia Therapeutics, building exterior and company sign, Cambridge, Massachusetts, USA.

Spencer Grant | Universal Images Group | Getty Images